|
|
||||||||






* Tropical Disease Research Unit, University of California, San Francisco, CA 94143;
Institutes of Evolution, Immunology, and Infection Research, University of Edinburgh, Edinburgh, United Kingdom;
Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021;
Institute of Infectious Disease and Molecular Medicine, University of Capetown, South Africa; and
¶ Trudeau Institute, Saranac Lake, NY 12983
| Abstract |
|---|
|
|
|---|
) are found in abundance during chronic Th2 inflammatory responses to metazoan parasites. Important roles for these macrophages are being defined, particularly in the context of Th2-mediated pathology and fibrosis. However, a full understanding of the requirements for alternative activation, particularly at the innate level, is lacking. We present evidence that alternative activation by the Th2 cytokines IL-4 and IL-13 is an innate and rapid response to tissue injury that takes place even in the absence of an infectious agent. This early response does not require CD4+ Th2 cells because it occurred in RAG-deficient mice. However, class II-restricted CD4+ T cell help is essential to maintain AAM
in response to infection, because AAM
were absent in RAG-deficient and MHC class II-deficient, but not B cell-deficient mice after chronic exposure to the nematode parasite, Brugia malayi. The absence of AAM
was associated with increased neutrophilia and reduced eosinophilia, suggesting that AAM
are involved in the clearance of neutrophils as well as the recruitment of eosinophils. Consistent with this hypothesis, AAM
show enhanced phagocytosis of apoptotic neutrophils, but not latex beads. Our data demonstrate that alternative activation by type 2 cytokines is an innate response to injury that can occur in the absence of an adaptive response. However, analogous to classical activation by microbial pathogens, Th2 cells are required for maintenance and full activation during the ongoing response to metazoan parasites. | Introduction |
|---|
|
|
|---|
)5 remain ill defined, their prevalence in chronic type 2 inflammatory conditions such as parasite infection (2, 3, 4, 5, 6, 7) and allergy (8, 9, 10) strongly suggests an important function under type 2 conditions. The importance of AAM
during parasitic infection has been confirmed using mice in which the IL-4R
is specifically deleted from macrophages, significantly altering the outcome of infection with both protozoan and metazoan parasites (11, 12). It has been suggested that these macrophages are involved in tissue remodeling and wound healing (13), and our own data strongly support this (3). Furthermore, there is increasing evidence that AAM
play a role in tumorigenesis (14, 15), which has sometimes been compared with wound healing gone wrong (16). However, the origin and life cycle of these cells, as well as the cells and mediators that are necessary for the induction and upkeep of AAM
, have not been well characterized beyond a requirement for type 2 cytokines.
This is in contrast to the type 1 proinflammatory pathway in which the interplay between innate and adaptive immunity has been a major focus of the immunology field for the past decade (17, 18). The importance of macrophage or neutrophil activation via the engagement of TLRs (19) or by the IFNs (
or
) (20) during the early phase of an acute microbial infection is increasingly well understood. Subsequent Th1 cell development promotes more effective macrophage killing that is essential in the control of many intracellular pathogens (21). We wished to investigate the requirements for macrophage activation in the context of infection with nematode parasites, which typically induce potent type 2 responses.
Our previous studies have shown that infection of mice with the filarial nematode, Brugia malayi, leads to the recruitment of large numbers of AAM
to the peritoneal cavity (2, 22). These macrophages have an IL-4-dependent phenotype that is sustained throughout several weeks of infection. This includes the suppression of cellular proliferation in a contact-dependent manner (2) and the expression of the molecules Ym1/Chi3l3, Fizz1/Relm-
, and arginase 1 (3, 23), which are now considered reliable markers of alternative macrophage activation (1, 6, 7). We thus chose to use this in vivo system to investigate alternative activation during both the early and late stages of a type 2 immune response. Our findings reveal that type 2-dependent alternative activation can occur very early in the immune response, independent of the adaptive arm of the immune system and independent of infection. However, maintenance of the full alternative macrophage activation phenotype requires CD4+ T cells. These studies suggest that analogous to type 1 proinflammatory processes, alternative type 2 activation needs to be considered both in terms of an early innate response and later adaptive immune response, with distinct mediators and functions at each stage.
| Materials and Methods |
|---|
|
|
|---|
For all experiments, mice used were 6–12 wk old at the start of the experiment. All mice were bred and maintained in accordance with the animal care and use regulations of either University of California, University of Edinburgh, or Trudeau Institute. Breeding stocks of RAG1–/– and MHC class II–/– mice (on the C57BL/6 background) as well as wild-type (WT) C57BL/6 control mice were obtained from The Jackson Laboratory. C57BL/6 IL-4–/– were originally purchased from B&K Universal with permission of the Institute of Genetics, University of Cologne. BALB/c IL-4R
-deficient mice (24) and C57BL/6 µMT (25) and WT control mice were bred in house. Both male and female mice were used with identical results. The 4get mice (C.129-Il4tm1Lky/J) were generated, as previously described (26), and backcrossed to BALB/c for 10 generations.
Nematode implant and surgery
B. malayi adult parasites were obtained from infected gerbils purchased from TRS Laboratories or maintained in house. Adult worms were removed from the peritoneal cavity of gerbils and washed in RPMI 1640. Under anesthesia, a small surgical incision is made through both the skin and the peritoneal membrane of the mouse, and five live adult B. malayi females are introduced in a volume of up to 1 ml. The incision is closed with the use of a medical stapler. Animals undergo sham surgery following the above steps, but with no parasites introduced. After 3–6 wk (or times indicated in the text), mice were euthanized by cardiac puncture and peritoneal exudate cells (PEC) were harvested by thorough washing of the peritoneal cavity with 15 ml of ice-cold RPMI 1640 medium. For thioglycolate-induced macrophages, mice were injected with 4% thioglycolate for 48–96 h before PEC were harvested.
Suppression assay
Peritoneal lavage cells were plated at 1 x 106 cells/ml. Following 2- to 3-h adherence at 37°C, the nonadherent cells were removed, leaving a cell population highly enriched for macrophages (routine >85% F4/80+). Adherent PEC were cocultured in 96-well flat-bottom plates with EL-4 cells (1 x 104 cells/well) for 48 h. A total of 1 µCi of [3H]TdR in 10 µl of complete medium was then added to each well. Plates were incubated overnight before harvesting and counting using a liquid scintillation counter (Micro
1450; Trilux). Triplicate or quadruplicate measurements per sample were performed. Results were plotted as cpm.
Real-time PCR
Total RNA was isolated using either TRIzol (Invitrogen Life Technologies) or Tri reagent (Sigma-Aldrich), and cDNA was synthesized using either Moloney murine leukemia virus reverse transcriptase (Stratagene) or Superscript II (Invitrogen Life Technologies). Real-time PCR of the cDNA was conducted using either the Roche LightCycler or a GeneAmp 5700 (Applied Biosystems). Serial dilutions of a positive control sample of cDNA were used as a standard curve in each reaction. The level of each gene was expressed as a ratio to the level of either actin or GAPDH to control for differing levels of cDNA in each sample. The results are shown as arbitrary units. The primers have been described previously (3).
FACS, cytospin analysis, and ELISA
For FACS analysis, cells (2–5 x 105) were preincubated with unlabeled
-CD16/32 (24G2), and then incubated with
-F4/80 (Caltag Laboratories) and anti-Ly6G (eBioscience). Cytocentrifuge preparations of 1 x 105 cells were made using a Shandon Cytospin 3 (Thermo Shandon). Cytospins were air dried, fixed in methanol, stained with GIEMSA (Sigma-Aldrich) or Diff-Quik reagent (Dade Behring), and examined with a microscope for differential cell counting. For analysis of PEC from 4get mice, adherent cells were depleted by incubation in culture dishes in RPMI 1640 for 1 h at 37°C and flow cytometry was performed, as previously described (27). For splenocyte recall assays, 1 x 106 cells were stimulated with medium alone or B. malayi Ag (5 µg/ml). Following stimulation for 84 h, 100 µl of supernatant was removed for cytokine assays. The IL-13 concentration was determined by capture ELISA using the Quantikine mouse IL-13 immunoassay kit (R&D Systems), according to the manufacturers instructions.
Ag presentation and phagocytosis assays
Macrophages from the peritoneal cavity were purified by adherence in 24-well plates and incubated for 30 min at 37°C with FITC-labeled latex beads (Sigma-Aldrich) or CFSE-labeled human apoptotic neutrophils provided by the Centre for Inflammation Research (University of Edinburgh). The phagocytosis of beads/neutrophils was assessed by microscopic visualization of the wells or by FACS.
Statistical analysis
Unless otherwise stated, data between groups were compared with two-tailed unpaired Students t test using Prism 3.0 (GraphPad) with a normality test. Error bars always show variation between individual mice.
| Results |
|---|
|
|
|---|
Our experimental model involves the surgical implant of nematode parasites into the peritoneal cavity of mice through a small incision in the peritoneal wall. We had previously noted that some of the markers associated with alternative macrophage activation were seen in the first 1–3 days in both implanted mice and control mice that underwent the surgical procedure only (3). To further investigate this finding, we assessed whether arginase 1, a AAM
marker known to be associated with wound repair (28), displayed a similar pattern in parasite-implanted and surgery-only mice. We also compared cell recruitment in these two groups of mice to assess whether cell recruitment patterns differed at these early time points.
As seen previously with Ym1 and Fizz1 (3), arginase 1 mRNA was transiently elevated in PEC in response to surgical trauma and returned to baseline by 1 wk postsurgery. In contrast, animals with implanted parasites exhibited elevated arginase levels throughout the 3-wk course of the experiment (Fig. 1A). The total numbers of cells recruited into the peritoneal cavity were similar between surgery-only and parasite-implanted mice in the first 3 days, suggesting that the early cell recruitment is driven as much by surgical intervention as parasite presence (Fig. 1B). A breakdown of specific cell types indicated that the cell recruitment patterns were statistically indistinguishable in the first 3 days, with the one exception that parasite implant led to an immediate increase in eosinophils at 24 h (6.7 ± 3.0 x 105) that was less pronounced in the surgery-only mice (0.7 ± 0.3 x 105). The presence of the parasite, however, led to a further increase in total cell numbers that was still rising at 3 wk when the experiment was terminated with parasites still present (Fig. 1B). As previously published, the sustained cellular exudate was comprised of eosinophils, macrophages, and lymphocytes, with macrophages representing >70% of the total cell composition (29). In contrast, by day 10, the cell numbers in surgery-only mice had declined, but macrophages and lymphocytes remained somewhat elevated for the remainder of the experiment (data not shown). Thus, the drop in arginase seen above was not simply a reflection of the drop in macrophage numbers, suggesting that either alternative activation is short-lived in this setting or the alternatively activated cells are specifically taken up by the wound itself. As noted previously by ourselves and others (29, 30), parasite implant led to an early rise in neutrophil numbers that declined as eosinophil and macrophage numbers increased.
|
in wound healing after physical trauma. The proper progression of wound healing can only occur if the initial inflammatory response is controlled (32, 33, 34, 35), and this would be consistent with the suppressive function of these macrophages. Analysis of nematode-elicited macrophage cytokine production by cytokine bead array has revealed that they produce abundant IL-10 and IL-6 (data not shown), cytokines consistent with both anti-inflammatory and wound healing functions. We therefore assessed mRNA profiles of PEC from nematode-implanted mice and sham surgery mice to determine whether the types and amounts of cytokines were similar. IL-10 (Fig. 1D) and IL-6 (data not shown) followed a similar profile as the alternative marker arginase (Fig. 1A). Ym1, Fizz1, and arginase 1 up-regulation in response to surgery occurs independently of T or B cells, but requires IL-4 and/or IL-13
The rapid elevation (1–3 days) and then decline (3–5 days) in Ym1, Fizz1 (3), and arginase 1 (Fig. 1A) suggested that these proteins are part of the innate response to surgical trauma. To ask whether these responses could occur in the absence of adaptive immunity, we performed the surgical procedure on RAG–/– mice that lack both B and T cells. Ym1, Fizz1, and arginase 1 mRNA were all elevated in response to the surgical procedure, and there was no significant difference between WT and RAG–/– mice (Fig. 2A). Thus, this early response is entirely innate with no requirement for B or T cells. These data also illustrated subtle differences in kinetics that we consistently observe. Ym1 expression peaks at 24 h, whereas Fizz1 and arginase 1 are slightly delayed, with expression peaking at 72 h.
|
Ym1, Fizz1, and arginase 1 expression has previously been shown to be strictly dependent on IL-4 on the C57BL/6 background following a 3-wk implant with B. malayi (3, 23). However, on the BALB/c background, an absence of IL-4 was insufficient to prevent alternative activation, and the absence of both IL-4 and IL-13 signaling was required (our unpublished observation). We hypothesized that in the absence of IL-4, C57BL/6 mice fail to develop Th2 cells that produce IL-13, but in the more Th2-prone BALB/c mouse, IL-13 may still be produced. To address this, we measured IL-13 production by splenocytes from naive and implanted WT and IL-4-deficient mice on both C57BL/6 and BALB/c backgrounds. Indeed, we found that IL-4-deficient mice on the BALB/c background make considerable amounts of IL-13 in response to B. malayi implant, whereas on the C57BL/6 background little IL-13 is produced in the absence of IL-4 (Fig. 3). These data suggested that in vivo IL-13 may have an equal or greater role to play than IL-4 in the induction of Ym1 and Fizz1. We thus chose to use the IL-4R
-deficient mice to assess whether the inability of IL-4 to affect Ym1 expression during the early injury response could be explained by the presence of IL-13. These experiments were performed on the BALB/c background because this was the only strain available to us. We found that indeed in the absence of IL-4R signaling, there was a near complete ablation of Ym1 expression relative to BALB/c controls, whereas Fizz1 and arginase 1 were entirely absent (Fig. 2C). Thus, the IL-4R
–/– mice demonstrate that innate expression of Ym1, Fizz1, and arginase 1 requires either IL-4 or IL-13. Different target cells for IL-4 vs IL-13 may explain the subtle differences in expression kinetics for these alternative activation markers.
|
–/– mice, granulocyte numbers (both eosinophils and neutrophils) were reduced relative to WT (Fig. 4).
|
50% eosinophils and 40% mast cells (Fig. 5, A and B). Ten percent were Th2 cells, but these are not a possible source of early IL-4 in the RAG–/– experiments. In addition, we assessed the GFP+ cells after surgery and found that the mast cell population was dramatically reduced, consistent with our previous cytospin analyses, and that now eosinophils represented >90% of the cells positive for IL-4 mRNA.
|
during nematode infection requires the adaptive immune responseBecause our surgery experiments demonstrated the absence of a requirement for the adaptive immune system in the generation of the alternatively activated phenotype, we chose to examine whether the sustained activation of macrophages we see during nematode infection could also occur independently of adaptive immunity. To test this, we implanted B. malayi into the peritoneal cavities of RAG1–/– mice for 3 wk. Control RAG1–/– mice injected with thioglycolate recruited equal numbers of peritoneal cells (Fig. 6A), with similar percentages of F4/80+ macrophages (data not shown) as WT mice, indicating that there is no inherent macrophage recruitment defect in RAG1–/– mice. In contrast, there was a dramatic difference in the number of cells recruited by the parasites in WT vs RAG1–/– mice (Fig. 6A). Although peritoneal cells in RAG1–/– naive mice increased from 5 x 105 cells per mouse (compared with 2.5 x 106 cells in WT mice), to a mean of 1.55 x 106 (±4.4 x 105) cells after infection. This was much less than the mean of 1.63 x 107 (±3.8 x 106) cells recruited in WT mice.
|
, we looked by real-time PCR for the expression of Ym1, Fizz1, and arginase 1. Although cell recruitment was very low in RAG1–/– mice, sufficient cells were present for mRNA analysis. Cells isolated from RAG1–/– mice did not display significant expression of Ym1, Fizz1, or arginase 1 (Fig. 6B) and were similar to thioglycolate controls (data not shown). Analysis of adherent cells enriched further for macrophages showed similar results (data not shown). These results suggest that either B or T cells are required for a sustained presence of AAM
. Of note, inducible NO synthase was elevated in the implanted RAG–/– mice, suggesting that the small numbers of cells recruited were in a classical activation state.
CD4+ T cells, but not B cells, are required to maintain AAM
during an adaptive immune response
We predicted that CD4+ T cells were the most likely component of adaptive immunity that would be required for AAM
recruitment. Hence, we implanted parasites into mice lacking class II MHC (MHC II–/–), which are defective in selecting for CD4+ T cells (37) and are a better model for T cell help than CD4-deficient mice, in which the CD8 population is heavily contaminated with MHC class II-restricted T cells (38). There was a striking reduction in the number of total cells recruited after implantation of MHC II–/– mice (Fig. 7A). There were also fewer F4/80+ macrophages recruited in these mice (Fig. 7B), consistent with our previous study of nude mice (22). Thioglycolate-injected MHC II–/– mice recruited similar numbers of macrophages and PEC as WT mice (Fig. 7A). Expression of Ym1 and Fizz1 mRNA was reduced to control levels in parasite-implanted MHC II –/– mice (Fig. 7C). Thus, class II-restricted T cell help is apparently required for the sustained recruitment and differentiation of AAM
in vivo.
|
differentiation and maintenance. We therefore implanted parasites into B cell-deficient µMT mice and looked for the expression of AAM
marker genes. In contrast to the analysis of RAG1–/– and MHC II –/– mice, identical numbers of peritoneal cells, including F4/80+ macrophages, were recruited in µMT mice (data not shown), which expressed comparable levels of AAM
genes as WT mice after parasite implantation (Fig. 7D).
AAM
induced during an adaptive immune response may mediate clearance of early neutrophilia
To determine whether there were any changes in the composition of cell types in MHC II–/– mice, we compared the inflammatory PEC by FACS and cytospin analysis. We observed an increase in neutrophils and a marked decrease in eosinophils (Fig. 8). The reduction of eosinophils was not surprising and is consistent with the known role of Th2 cytokines in eosinophil development and recruitment (39). Ramalingam et al. (30) have also shown that CD4+ cells play a role in recruiting eosinophils in the closely related Brugia pahangi infection model. However, the increase in neutrophilia was unexpected. Parasite-implanted RAG–/– mice also had elevated neutrophils similar to MHC II–/– mice (data not shown). The sustained presence of neutrophils in mice lacking AAM
suggested that AAM
might also play a role in the clearance of neutrophils. Hence, we used an in vitro system to determine whether AAM
could phagocytose neutrophils. We found that AAM
from parasite-implanted WT mice were significantly better at phagocytosing neutrophils than thioglycolate-induced macrophages (Fig. 9). In contrast, there was no difference in their ability to phagocytose latex beads (Fig. 9). Macrophages from C57BL/6 IL-4–/– mice were as capable as macrophages from WT mice at phagocytosing neutrophils. This is consistent with the fact that we did not observe an increase in neutrophilia in C57BL/6 IL-4–/– mice, even though macrophages from these mice do not possess the markers of alternative macrophage activation (2, 3, 23, 31) These data suggest that macrophages in the nematode infection setting are influenced by factors other than IL-4 alone.
|
|
| Discussion |
|---|
|
|
|---|
–/– mice demonstrated that innate expression of Ym1, Fizz1, and arginase 1 requires either IL-4 or IL-13, as previously reported for allergy, fibrosis, and infection (45, 46, 47, 48).
The innate source of IL-4 or IL-13 triggering this injury response has yet to be identified, but is likely to be eosinophils or mast cells. Analysis of 4get mice revealed that eosinophils, mast cells, and Th2 cells were the only populations in the peritoneal cavity of naive mice expressing IL-4 mRNA. Very few basophils were present. T cells can be excluded because we observed the IL-4R
-dependent injury response in RAG-deficient mice. Following surgery, there was a dramatic increase in the numbers of IL-4+ eosinophils accompanied by a drop in mast cell numbers. Eosinophils have been previously identified as innate IL-4-producing cells in Nippostrongylus brasiliensis (49), Schistosoma mansoni (42), and Heligomosoides polygyrus infection (36). Although these data implicate eosinophils as the trigger for alternative activation, mast cells cannot be ruled out. Mast cells are considered sentinels of tissue injury (50) and are known to rapidly produce IL-4 or IL-13 (27, 51). The rapid decline in mast cells following surgery may reflect degranulation or activation-induced adherence to the peritoneal wall with release of cytokine stores.
Recently, Reece et al. (52), using the N. brasiliensis model, demonstrated innate expression of ym1, fizz1, and arg1 in the lungs of infected SCID mice. Because N. brasiliensis migration leads to severe lung damage, the study supports a role for these proteins as responders to tissue injury. However, it is not possible to determine whether the response was the result of tissue damage or helminth Ags. Our study demonstrates that an innate type 2 response will occur solely in response to physical trauma. An intriguing twist to this story is the recent discovery that chitin, a molecule found in many pathogens and allergens, but not in mammals, leads to rapid alternative activation through recruitment of IL-4-expressing cells (53). Because chitin is unlikely to be found in our sterile surgical procedure, it raises the possibility that endogenous activators of IL-4 include chitin-like sugars. Ym1 itself is a molecule that can bind chitin, but also has the ability to bind an array of host sugars (54). The finding that Ym1 is needed for Th2 cell activation (55) suggests that it may play a role in triggering activation by these sugars. This raises the question as to whether there are fundamental differences in alternative activation by endogenous ligands vs pathogen-derived molecules. We have found that the ability of some parasite-derived molecules to induce AAM
(29) is entirely dependent on IL-4 or IL-13 (our unpublished observation) as is the innate wounding response described in this work. Thus, the key factor seems to be the ability to induce IL-4 and/or IL-13. Whether parasite and host factors are acting through distinct (and thus potentially additive) pathways has yet to be determined. However, in our study, the sham surgery response was as great as that seen with surgical parasite implant, suggesting that the wounding response was dominant and the parasite at these early stages was not augmenting this response.
The main difference between sham surgery and parasite implant was the sustained Th2 cell-dependent response. With the knowledge that alternatively activated macrophages are part of the innate response, this raises an additional question about their role in Th2 cell induction. We have shown in vitro that macrophages from Brugia-implanted mice can prime naive T cells to differentiate into Th2 cells (56), and Ym1 has been shown to be an important DC factor involved in Th2 differentiation (55). These data along with the knowledge that inflammatory macrophages can traffic to the draining lymph nodes to prime T cell responses (57) would support a role for these macrophages in Th2 induction. However, we have also shown that AAM
, unlike T regulatory cells, do not become detectable in the draining lymph nodes of filarial-infected mice until the infection becomes systemic (58), arguing against a role in early induction of Th2 cells. Regardless of whether the AAM
play a role in Th2 induction, the data do suggest they are involved in orchestrating the sequence of events. We have previously found that there is an early influx of neutrophils during the acute phase of the response, but they are gradually replaced by eosinophils and are essentially gone after 2 wk (29), and this pattern was observed again in this study (data not shown). A recent study demonstrated that AAM
contribute significantly to eosinophil recruitment (59). Put together with our finding that AAM
may also mediate neutrophil clearance, a model is suggested whereby macrophages orchestrate the cell recruitment profile during type 2 inflammation, through an initial clearance of neutrophils, followed by the recruitment of eosinophils, with Th2 cells required for the second phase. Whether they are also responsible for Th2 induction and whether wound AAM
vs parasite AAM
differ in this regard still needs to be addressed.
Our previous work points to AAM
as the main source of Fizz1, Ym1, and arginase 1 in the peritoneal population (3, 23). However, neutrophils may be an important source of these proteins at early time points because they have been shown to contain Ym1 (60) and are the predominant cell in WT and RAG–/– mice in the first 24–48 h (this study) (29), but are significantly reduced in the IL-4R–/– mice that failed to express AAM
-associated markers. Evidence also suggests that neutrophils can be classified into classical or alternative categories (61). Additionally, eosinophils were significantly elevated at 1 and 3 days postsurgery and can express both Fizz1 (49) and Ym1 (our unpublished observations). Although arginase expression has been described in human granulocytes, in mouse studies to date, Th2-inducible arginase has only been described in macrophages (62). Differential expression of Ym1 (peaking at day 1) as compared with Fizz 1 and arginase 1 (peaking at day 3) could suggest that different cell types are responsible for the early production of these proteins.
Although our data provide strong evidence for alternative activation as a part of the innate response to injury, the expression of these markers was transient. Only in the presence of the helminth parasite were macrophage numbers as well as AAM
-associated markers sustained. This required the adaptive immune response because AAM
were absent in the RAG–/– mice at later time points, contrasting directly with the injury response. Consistent with this finding, expression of AAM
markers during N. brasiliensis infection declines after 1 wk in SCID, but not WT mice (52). Our results show that the component of the adaptive immune response required to sustain alternative macrophage activation are class II-restricted CD4+ T cells with no requirement for B cells. Specifically, because the expression of these genes is dependent on type 2 cytokines, it is Th2 cells that are required. Interestingly, costimulation through CD28 is not necessary for this component of CD4+ T cell function (63). This is consistent with the completely normal Th2 response observed in CD28-deficient mice infected with a different nematode parasite H. polygyrus (64). Additionally, we have shown that despite a role in the induction of type 2 Abs, ICOS costimulation is also not required for the AAM
phenotype (63).
The observation that T cell help is required for alternative macrophage activation is important because CD4+ T cells are known to be essential for the formation of immune granulomas, which play a role in protecting both the host and the parasite (30, 65). In the mouse schistosomiasis model, CD4+ T cells have been shown to play a role in granuloma formation through studies with MHC class II-deficient mice and through anti-CD4 depletion experiments (66, 67). More recently, macrophages expressing high levels of arginase 1 have been implicated in the deposition of collagen and formation of fibrotic granulomas (7). Our results suggest that the recruitment of AAM
could be a crucial mechanism through which CD4+ T cells are involved in fibrotic granuloma formation. Our results would suggest that AAM
could also be key intermediaries between CD4+ Th2 cells in asthma and downstream effects such as eosinophil recruitment (59) and tissue remodeling (through arginase 1/Ym1) (10).
It is important to stress that although IL-4/IL-13-mediated responses may be important in tissue repair, they do not appear to be essential. Although we have never directly quantified the rate of wound repair in our surgery model, the incision is effectively healed in the mice that lack IL-4 or IL-4R. Nonetheless, the importance of type 2 cytokines in damaging tissue remodeling and fibrosis is increasingly well documented (1, 68). It now becomes important to ask the following: what is the role of type 2 cytokines in normal repair, and why do helminth parasites induce an immune response that has as a primary function wound healing? The answer to the second question may lie with the propensity of many parasites to induce potentially lethal tissue damage. Hookworm parasites penetrate the gut wall to feed, whereas schistosome eggs use proteolytic enzymes to enter the gut. Both situations could potentially lead to sepsis, unless the repair of gut wall was rapid and effective, thus providing sufficient evolutionary pressure for the development of a worm-specific tissue repair process (69). Indeed, S. mansoni infection of mice that lack AAM
is fatal due to endotoxemia (11), potentially explained by the inability of these mice to repair a breach of the intestinal wall. Similarly, many helminthic parasites have a migratory stage through the lung that leads to substantial pulmonary hemorrhaging that is repaired remarkably quickly (70).
We hypothesize that IL-4 and/or IL-13 may mediate a more rapid form of tissue repair that is necessary to maintain tissue integrity. This may be at the expense of higher quality repair. Consistent with this hypothesis, Eming et al. (71) demonstrated accelerated closure of skin punch biopsy wounds in IL-10-deficient mice, but at the cost of biomechanical strength. Importantly, Ym1-expressing macrophages were more abundant in the rapidly healing mice. The well-described anti-inflammatory properties of AAM
(1) are also consistent with a role for these cells in accelerating the rate of tissue repair, because effective healing cannot progress until classical inflammation has ended (32, 33, 34, 35). To test these hypotheses, it will be necessary to develop or identify both helminth and nonhelminth models in which the rate of repair is a determining factor in outcome.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by the Howard Hughes Medical Institute, the Wellcome Trust, and the Medical Research Council (U.K.). P.L. is a recipient of a Wellcome International Research fellowship; M.G.N. is a recipient of a Wellcome Prize fellowship; and I.G. is the recipient of a Wellcome Trust prize PhD studentship. ![]()
2 P.L. and I.G. contributed equally to this work. ![]()
3 Current address: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104. ![]()
4 Address correspondence and reprint requests to Dr. Judith Allen, Institutes of Evolution, Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom. E-mail address: j.allen{at}ed.ac.uk ![]()
5 Abbreviations used in this paper: AAM
, alternatively activated macrophage; PEC, peritoneal exudate cell; WT, wild type. ![]()
Received for publication April 13, 2007. Accepted for publication July 3, 2007.
| References |
|---|
|
|
|---|
/
system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14: 111-116. [Medline]
-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162: 7302-7308.
and interleukin-4 in response to Th1- and Th2-stimulating pathogens by 
T cells in vivo. Nature 373: 255-257. [Medline]
(o)) mice infected by the parasite Schistosoma mansoni. Scand. J. Immunol. 48: 159-169. [Medline]This article has been cited by other articles:
![]() |
E. Thorp and I. Tabas Mechanisms and consequences of efferocytosis in advanced atherosclerosis J. Leukoc. Biol., November 1, 2009; 86(5): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Maizels, E. J. Pearce, D. Artis, M. Yazdanbakhsh, and T. A. Wynn Regulation of pathogenesis and immunity in helminth infections J. Exp. Med., September 28, 2009; 206(10): 2059 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Lee, D. Hartl, G. R. Lee, B. Koller, H. Matsuura, C. A. Da Silva, M. H. Sohn, L. Cohn, R. J. Homer, A. A. Kozhich, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis J. Exp. Med., May 11, 2009; 206(5): 1149 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Prieto-Lafuente, W. F. Gregory, J. E. Allen, and R. M. Maizels MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages J. Leukoc. Biol., May 1, 2009; 85(5): 844 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Nair, Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung J. Exp. Med., April 13, 2009; 206(4): 937 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mylonas, M. G. Nair, L. Prieto-Lafuente, D. Paape, and J. E. Allen Alternatively Activated Macrophages Elicited by Helminth Infection Can Be Reprogrammed to Enable Microbial Killing J. Immunol., March 1, 2009; 182(5): 3084 - 3094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D'Elia, J. M. Behnke, J. E. Bradley, and K. J. Else Regulatory T Cells: A Role in the Control of Helminth-Driven Intestinal Pathology and Worm Survival J. Immunol., February 15, 2009; 182(4): 2340 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Siracusa, J. J. Reece, J. F. Urban Jr., and A. L. Scott Dynamics of lung macrophage activation in response to helminth infection J. Leukoc. Biol., December 1, 2008; 84(6): 1422 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Reece, M. C. Siracusa, T. L. Southard, C. F. Brayton, J. F. Urban Jr., and A. L. Scott Hookworm-Induced Persistent Changes to the Immunological Environment of the Lung Infect. Immun., August 1, 2008; 76(8): 3511 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Herbert, T. Orekov, C. Perkins, M. E. Rothenberg, and F. D. Finkelman IL-4R{alpha} Expression by Bone Marrow-Derived Cells Is Necessary and Sufficient for Host Protection against Acute Schistosomiasis J. Immunol., April 1, 2008; 180(7): 4948 - 4955. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |